Viridian Therapeutics Stock Performance
as on September 9, 2026 at 6:59 am IST
Day's Low
Day's High
$22.22$23.84
4.10%
Downside
2.89%
Upside
52 Week's Low
52 Week's High
$13.18$34.2943.12%
Downside
47.99%
Upside
Viridian Therapeutics share price movements today
- Previous Close
- $22.92
- Open
- $22.43
- Volume
- 1.5M
- Market Cap
- $2.6B
- Day's Low - High
- $22.22 - $23.84
- 52 Week Low - High
- $13.18 - $34.29
Viridian Therapeutics Historical Returns
- 1 Month Return
- -2.84 %
- 3 Month Return
- + 45.25 %
- 1 Year Return
- + 22.44 %
- 3 Year Return
- + 22.37 %
- 5 Year Return
- + 87.87 %
Viridian Therapeutics Stock Fundamentals & Key Indicators
Check Viridian Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.6B
EPS (TTM)
-3.53
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.49
Industry PE ratio
-14.02
PEG Ratio
-0.7201875918744672
EBITDA
-368.0M
Revenue (TTM)
71.1M
Profit Margin
99.55%
Return On Equity TTM
-61.35%
Viridian Therapeutics Stock Valuation
Track how Viridian Therapeutics P/E has moved over time to understand its valuation trends.
Viridian Therapeutics in the last 5 years
Lowest (-9.37x)
December 31, 2025
Industry (-14.02x)
December 31, 2025
Today (-9.37x)
December 31, 2025
Highest (-2.97x)
December 31, 2021
Today’s Price to Earnings Ratio: -9.37x
Viridian Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Viridian Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $2.6B | 87.87% | -6.49 | 99.55% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $138.4B | 184.14% | 31.53 | 86.04% | NA | |
| BUY | $58.1B | -66.65% | -18.24 | -12.57% | NA | |
| BUY | $85.2B | 23.76% | 19.76 | 84.86% | 0.44999999999999996% |
Stock Returns calculator for Viridian Therapeutics Stock including INR - Dollar returns
The Viridian Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Viridian Therapeutics investment value today
Current value as on today
₹1,33,390
Returns
₹33,390
(+33.39%)
Returns from Viridian Therapeutics Stock
₹23,771 (+23.77%)
Dollar Impact
₹9,618 (+9.62%)
Analyst Recommendation on Viridian Therapeutics Stock
Based on 13 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 13 analysts, 100% of analysts recommend a 'BUY' rating for Viridian Therapeutics. Average target price of $36.62
Viridian Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Viridian Therapeutics.
What analysts predicted
36.73%UPSIDE
Target Price
$36.62
Current Price
$23.17
Analyzed by
13 Analysts
Target
$36.62
Viridian Therapeutics target price $36.62, a slight upside of 36.73% compared to current price of $23.17. According to 13 analysts rating.
Indian Investors' Interest in Viridian Therapeutics Stock
Search interest for Viridian Therapeutics Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Viridian Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Viridian Therapeutics Annual Profit & Loss
All numbers in Millions USD
Viridian Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Viridian Therapeutics Annual Cash Flow
All numbers in Millions USD
Viridian Therapeutics News & Key Events
Today's Timeline - 29 June
Mon, 06:54 PM
-FDA approves Viridian's Lumvoa for thyroid eye disease, marking a significant milestone for the company.
Insights on Viridian Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 132.0K → 284.0K (in $), with an average increase of 28.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, VRDN stock has moved up by 40.5%
NO EFFECTAgainst Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 35.2% return, outperforming this stock by 9.1%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 494.8% return, outperforming this stock by 481.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -104.90M → -127.11M (in $), with an average decrease of 21.2% per quarter
About Viridian Therapeutics
| Organisation | Viridian Therapeutics |
| Headquarters | 221 Crescent Street, Waltham, MA, United States, 02453 |
| Industry | Biotechnology |
| CEO | Mr. Stephen F. Mahoney J.D., MBA |
| E-voting on shares | Click here to vote |
Key Management of Viridian Therapeutics
Name | Title |
|---|---|
Mr. Seth Harmon | Chief Financial Officer |
Mr. Thomas W. Beetham J.D., MBA | Chief Operating Officer |
Dr. Eric N. Olson Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Mr. Vahe Bedian Ph.D. | Co-Founder & Scientific Advisor |
Ms. Melissa Manno | Chief Human Resources Officer |
Mr. Stephen F. Mahoney J.D., MBA | CEO, President & Director |
Dr. Radhika Tripuraneni M.D., M.P.H. | Chief Medical Officer |
Dr. Michael R. Bristow M.D., Ph.D. | Co-Founder & Member of the Scientific Advisory Board |
Dr. Marvin H. Caruthers Ph.D. | Co-Founder & Scientific Advisory Board Member |
Ms. Jennifer Tousignant J.D. | Chief Legal Officer & Corporate Secretary |
FAQs
What is Viridian Therapeutics share price today?
Viridian Therapeutics share price today is $23.17 as on at the close of the market. Viridian Therapeutics share today touched a day high of $23.84 and a low of $22.22.
What is the 52 week high and 52 week low for Viridian Therapeutics share?
Viridian Therapeutics share touched a 52 week high of $34.29 on and a 52 week low of $13.18 on . Viridian Therapeutics stock price today i.e. is closed at $23.17,which is 32.43% down from its 52 week high and 75.80% up from its 52 week low.
What is Viridian Therapeutics's market capitalisation today?
Viridian Therapeutics market capitalisation is $0.00T as on .
How to invest in Viridian Therapeutics Stock (VRDN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Viridian Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viridian Therapeutics Shares that will get you 0.0647 shares as per Viridian Therapeutics share price of $23.17 per share as on September 9, 2026 at 1:29 am IST.
What is the minimum amount required to buy Viridian Therapeutics Stock (VRDN) from India?
Indian investors can start investing in Viridian Therapeutics (VRDN) shares with as little as ₹94.8175 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in Viridian Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Viridian Therapeutics share’s latest price of $23.17 as on September 9, 2026 at 1:29 am IST, you will get 0.4316 shares of Viridian Therapeutics. Learn more about
fractional shares .
What are the returns that Viridian Therapeutics has given to Indian investors in the last 5 years?
Viridian Therapeutics stock has given 87.87% share price returns and 28.04% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?